Area of research
Surgery · Transplantation
Research interest
Research interests include Medicine, Xenotransplantation, Transplantation, Antibody, Liver transplantation, and Hepatocellular carcinoma.
Engaging patients in organ transplant listing meetings: A survey study
Normothermic Machine Perfusion of Donor Livers for Transplantation in the United States
What Therapeutic Regimen Will Be Optimal for Initial Clinical Trials of Pig Organ Transplantation?
Suggested Patient Selection Criteria for Initial Clinical Trials of Pig Kidney Xenotransplantation in the United States
Evidence suggesting that deletion of expression of N‐glycolylneuraminic acid (Neu5Gc) in the organ‐source pig is associated with increased antibody‐mediated rejection of kidney transplants in baboons
Histopathology of pig kidney grafts with/without expression of the carbohydrate Neu5Gc in immunosuppressed baboons
Old World Monkeys are less than ideal transplantation models for testing pig organs lacking three carbohydrate antigens (Triple-Knockout)
Pig kidney xenotransplantation: Progress toward clinical trials
The final obstacle to successful pre‐clinical xenotransplantation?
Early Outcomes With the Liver-kidney Safety Net
Life-supporting Kidney Xenotransplantation From Genetically Engineered Pigs in Baboons: A Comparison of Two Immunosuppressive Regimens
Clinical Pig Kidney Xenotransplantation: How Close Are We?
HLA Class I–sensitized Renal Transplant Patients Have Antibody Binding to SLA Class I Epitopes
Mitigating Racial and Sex Disparities in Access to Living Donor Kidney Transplantation
Xenoantigen Deletion and Chemical Immunosuppression Can Prolong Renal Xenograft Survival
Examining the Biosynthesis and Xenoantigenicity of Class II Swine Leukocyte Antigen Proteins
Ethnic and Age Disparities in Outcomes Among Liver Transplant Waitlist Candidates
Humoral Reactivity of Renal Transplant-Waitlisted Patients to Cells From GGTA1/CMAH/B4GalNT2, and SLA Class I Knockout Pigs
Current guidelines for chemoembolization for hepatocellular carcinoma: Room for improvement?
Insurance Type and Solid Organ Transplantation Outcomes: A Historical Perspective on How Medicaid Expansion Might Impact Transplantation Outcomes
A SEER Database Analysis of the Survival Advantage of Transarterial Chemoembolization for Hepatocellular Carcinoma: An Underutilized Therapy
Does the Degree of Hepatocellular Carcinoma Tumor Necrosis following Transarterial Chemoembolization Impact Patient Survival?
The Impact of Proposed Changes in Liver Allocation Policy on Cold Ischemia Times and Organ Transportation Costs
Adjuvant stereotactic body radiotherapy following transarterial chemoembolization in patients with non‐resectable hepatocellular carcinoma tumours of ≥3 cm
Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): Phase 2 trial of stable liver transplant recipients
Transmission of Balamuthia mandrillaris Through Solid Organ Transplantation: Utility of Organ Recipient Serology to Guide Clinical Management
A Randomized Clinical Trial Testing the Anti-Inflammatory Effects of Preemptive Inhaled Nitric Oxide in Human Liver Transplantation
Risk Factors Associated with Reoperation for Bleeding following Liver Transplantation
Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolization
Chemoembolization outcomes for hepatocellular carcinoma in cirrhotic patients with compromised liver function